Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v22-FR | Version v17-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2024-10-30 | 2024-08-28 |
| Drug Identification Number | 00511552 | 00511552 |
| Brand name | SANDOMIGRAN DS | SANDOMIGRAN DS |
| Common or Proper name | SANDOMIGRAN DS 1mg Tabs | SANDOMIGRAN DS 1mg Tabs |
| Company Name | PALADIN PHARMA INC. | PALADIN PHARMA INC. |
| Ingredients | PIZOTIFEN | PIZOTIFEN |
| Strength(s) | 1MG | 1MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 100 Tabs | 100 Tabs |
| ATC code | N02CX | N02CX |
| ATC description | ANTIMIGRAINE PREPARATIONS | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2023-10-02 | 2023-10-02 |
| Estimated end date | 2024-12-15 | 2024-10-01 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Production delays | Production delays |
| Health Canada comments |